NCT03394300

Brief Summary

evaluation of the accuracy of iol power in high myopia using different biometry formula \& iol master

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2018

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 9, 2018

Completed
23 days until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
Last Updated

January 9, 2018

Status Verified

January 1, 2018

Enrollment Period

1 year

First QC Date

December 29, 2017

Last Update Submit

January 7, 2018

Conditions

High Myopia

Outcome Measures

Primary Outcomes (1)

  • accuracy of iol power in high myopia

    biometry assment of IOLpower

    one year

Interventions

iol power calculationOTHER

iol power calculation in high myopia

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

data will be collected from all patients who meet inclusion criteria

You may qualify if:

  • \- 1- patients with clear lense extraction or cataract \& high myope with{ AL more than 26 mm.
  • their IOLpower is less than 15 diopter or their refraction before operation is more than -6.

You may not qualify if:

  • Keratoconus patients or those with irregular cornea
  • Patients with post operative complications like posterior capsule injury or vitrous loss.
  • patients who had undergone previous intraocular surgery at anterior segment or posterior segment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ophthalmology resident

Study Record Dates

First Submitted

December 29, 2017

First Posted

January 9, 2018

Study Start

February 1, 2018

Primary Completion

February 1, 2019

Study Completion

February 1, 2019

Last Updated

January 9, 2018

Record last verified: 2018-01